Management of dengue fever l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 17

Management of Dengue Fever PowerPoint PPT Presentation


  • 363 Views
  • Uploaded on
  • Presentation posted in: General

Management of Dengue Fever . Dr David Tran 16/09/09. Classic clinical dengue fever. Incubation period 3 to 14 days (usually 4 to 7 days) Sudden onset of fever with severe headache Retro-orbital pain, fatigue Often associated with myalgia and arthralgia

Download Presentation

Management of Dengue Fever

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Management of dengue fever l.jpg

Management of Dengue Fever

Dr David Tran

16/09/09


Classic clinical dengue fever l.jpg

Classic clinical dengue fever

  • Incubation period 3 to 14 days (usually 4 to 7 days)

  • Sudden onset of fever with severe headache

  • Retro-orbital pain, fatigue

  • Often associated with myalgia and arthralgia

  • Duration of fever usually 5 to 7 days

  • Sometime maculopapular rash(50% to 66% of cases)

  • Other non specific signs as inflamed pharynx, gastro-intestinal symptoms


Classic definition of dengue fever who 1997 l.jpg

Classic definition of dengue fever(WHO 1997)


Hemorrhagic manifestations biologic abnormalities l.jpg

Hemorrhagic manifestations / biologic abnormalities

  • Petechiae, purpura

  • Gum bleeding, epistaxis, menorrhagia, gastro-intestinal bleedings (rare)

  • Thrombocytopenia, leukopenia with lymphopenia

  • Mild elevation of hepatic transaminases & LDH


Definition of dengue hemorrhagic fever who 1997 l.jpg

Definition of dengue hemorrhagic fever (WHO 1997)


Dengue hemorrhagic fever dengue shock syndrome l.jpg

Dengue hemorrhagic fever & Dengue shock syndrome

  • Physiopathology: capillary leakage & hemorrhagic manifestations.

  • 4 to 7 days after the onset (at approximately the date of defervescence)

  • Abdominal pain, vomiting, consciousness troubles, hypothermia

  • Marked decrease in platelet count.

  • Mortality: up to 10 or 20%


Definition of dengue shock syndrome who 1997 l.jpg

Definition of dengue shock syndrome (WHO 1997)


Diagnosis of dengue hemorrhagic fever triad of symptoms l.jpg

Diagnosis of dengue hemorrhagic fever (triad of symptoms)

  • Hemorrhagic manifestations

  • Platelet count < 100.000 (often >3rd day of illness)

  • Evidence of plasma leakage (Hematocrite  pleural effusion, ascites, hypoproteinemia)


Lowest platelet count by day of illness in adult dengue hemorrhagic patients l.jpg

Lowest platelet count by day of illness in adult dengue hemorrhagic patients


Dengue shock syndrome l.jpg

Dengue shock syndrome

  • Rapid weak pulse & low blood pressure (BP < 90mmHg)

  • The duration of this shock is short after appropriate volume replacement therapy (Colloid or Cristalloid infusions)

  • Mortality rate is up to 40%


Different clinical presentation of dengue fever l.jpg

Different clinical presentation of dengue fever


Serodiagnosis of dengue fever l.jpg

Serodiagnosis of dengue fever

  • Serology (IgM capture ELISA)

  • Problem: negativity of the test early in the course of the disease > should be performed only 4 to 5 days after the onset of fever.

  • IgM: remain positive for 3 to 6 month

  • IgG: remain positive for life


Dengue ns1 antigen testing l.jpg

Dengue NS1 antigen testing

  • Early detection of Ag NS1 in blood sample of infected patients > confirm early acute infection

  • Detection of all 4 types of dengue serotypes

  • Result available in 15 min. (BioRad® chromatographic strip test)

  • High specificity (100%) and positive predictive value


Slide14 l.jpg

Although in some reports, the same efficiency of detection for virus of the 4 serotypes has been described for the Dengue Early ELISA and Strip tests (Dussart et al., 2008), A recent analysis of the performance of these tests in Vietnam suggests a lower sensitivity for DENV-2 compared with DENV-1 and DENV-3.


Slide15 l.jpg

Problem of sensibility of NS1 detection tests(Ramirez, diagnostic microbiology & infectious disease, Sept 2009)

These tests in Vietnam suggests a lower sensitivity for DENV-2 compared with DENV-1 and DENV-3. Also, a decreased sensitivity for DENV-4 with the Dengue Early ELISA has been reported in studies from South America (Bessoff et al., 2008; Dussart et al., 2008).

A lower sensitivity for DENV-2 has been described in samples from Vietnam (Hang et al., 2009) tested by the PLATELIA™systems (ELISA and Strip) and belonging to the Asian genotype 1 (according to the classification of Twiddy et al., 2002).


Slide16 l.jpg

Sensitivity of NS1 Ag detection tests according to the day of illness(Mc Bride, Diagnostic Microbiology & Infectious Diseases, 64 – 2009 – 31,36)


Management of dengue virus infected patient l.jpg

Management of dengue virus infected patient

  • Most of cases can be managed on an outpatient basis (antipyretic like paracetamol, bed rest, oral hydratation)

  • Platelet counts and hematocrite determination should be repeated at least every 24 hours

  • Patient with platelet count < 100.000 should be hospitalized (high risk for dengue hemorrhagic & dengue shock syndrome)


  • Login